VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection)
暂无分享,去创建一个
Yibo Wang | Weili Zhang | Yuhui Zhang | Yue-jin Yang | Li-Zhong Sun | Shengshou Hu | Jilin Chen | Chan-na Zhang | Yi Zheng | Y. Zhen | K. Sun | Chun-yan Fu | Tao Yang | Jianwei Wang | Jing Sun | Haiying Wu | W. Glasgow | R. Hui
[1] M. Matsuoka. [Coagulation factors]. , 1961, Jibi inkoka Otolaryngology.
[2] C. Dolea,et al. World Health Organization , 1949, International Organization.
[3] P. Fernlund,et al. Vitamin K dependent modifications of glutamic acid residues in prothrombin. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[5] P. Reitsma,et al. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects. , 1991, Blood.
[6] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[7] P. Fitzgerald,et al. Contribution of Localized Calcium Deposits to Dissection After Angioplasty: An Observational Study Using Intravascular Ultrasound , 1992, Circulation.
[8] E. Puffenberger,et al. Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. , 1992, The Journal of clinical investigation.
[9] W. Lawson,et al. Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. , 1993, The Journal of laboratory and clinical medicine.
[10] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[11] M. Bots,et al. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. , 1995, Atherosclerosis.
[12] R E Pyeritz,et al. Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.
[13] R. Behringer,et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.
[14] D. Stafford,et al. A Missense Mutation in γ-Glutamyl Carboxylase Gene Causes Combined Deficiency of All Vitamin K-Dependent Blood Coagulation Factors , 1998 .
[15] P. Price,et al. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[16] R H Myers,et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. , 1998, Circulation.
[17] B. Dahlbäck,et al. Association of vitamin K-dependent coagulation proteins and C4b binding protein with triglyceride-rich lipoproteins of human plasma. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[18] D. Stafford,et al. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. , 1998, Blood.
[19] S E Humphries,et al. Genetic determinants of arterial thrombosis. , 1994, Bailliere's best practice & research. Clinical haematology.
[20] S. Kiechl,et al. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[21] E. Tremoli,et al. Tissue factor in atherosclerosis. , 1999, Atherosclerosis.
[22] J. Pritchard,et al. Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.
[23] C. Vermeer,et al. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. , 2000, Blood.
[24] A. Hofman,et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[25] C. Vermeer,et al. Novel mutation in the γ-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K–dependent blood coagulation factors , 2000 .
[26] José A López,et al. Cholesterol Sulfate: A New Adhesive Molecule for Platelets , 2001, Circulation.
[27] Roger D. Kamm,et al. The Impact of Calcification on the Biomechanical Stability of Atherosclerotic Plaques , 2001, Circulation.
[28] G. London,et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[30] Andreas Schober,et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.
[31] Platelets in Inflammation and Thrombosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[32] R. Hui,et al. Pentanucleotide TTTTA Repeat Polymorphism of Apolipoprotein(a) Gene and Plasma Lipoprotein(a) Are Associated With Ischemic and Hemorrhagic Stroke in Chinese: A Multicenter Case-Control Study in China , 2003, Stroke.
[33] P. Tam. The International HapMap Consortium. The International HapMap Project (Co-PI of Hong Kong Centre which responsible for 2.5% of genome) , 2003 .
[34] Kiang Liu,et al. Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events: A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate-Risk Adults , 2003, Circulation.
[35] Yibo Wang,et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. , 2003, Stroke.
[36] A. Khvorova,et al. Identification of the gene for vitamin K epoxide reductase , 2004, Nature.
[37] Andreas Fregin,et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 , 2004, Nature.
[38] K. Berkner,et al. The physiology of vitamin K nutriture and vitamin K‐dependent protein function in atherosclerosis , 2004, Journal of thrombosis and haemostasis : JTH.
[39] M. Fornage,et al. Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study , 2005, Human Genetics.
[40] D. Tregouet,et al. Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. , 2005, Blood.
[41] Deborah A Nickerson,et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. , 2005, The New England journal of medicine.
[42] M. Margaglione,et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. , 2005, Blood.
[43] Peter Wood,et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. , 2005, Blood.
[44] M. Charng,et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. , 2005, Human molecular genetics.
[45] S. Hunt,et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose , 2005, The Pharmacogenomics Journal.
[46] M. Shearer,et al. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1 , 2004, Thrombosis and Haemostasis.
[47] Yibo Wang,et al. Vitamin K Epoxide Reductase: A Protein Involved in Angiogenesis , 2005, Molecular Cancer Research.
[48] Tissue factor. , 2006, Seminars in thrombosis and hemostasis.